Organon

Our mission is to deliver impactful medicines and solutions for a healthier every day. We reserve the right to remove any comments that reference a product.

Organon is a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established medicines across a wide array of conditions and diseases. For more information, visit www.organon.com.

Commenting Guidelines:

Thank you for your interest in Organon. Providing useful and interesting content about our company and fostering open and respectful dialogue around specific topics is our ultimate goal. Organon respects the rights of individuals using social media to voice their views and opinions. However, within our social media channels, we reserve the right to remove comments that are considered inappropriate, off-topic, abusive, or being used to promote and solicit for third-party sites, initiatives or products. We ask that you please respect the following guidelines for our page:

Please refrain from mentioning Organon products or products from other companies. Comments or posts that are factually inaccurate or misleading, are spam, inappropriate, violate another’s copyright or intellectual property, use profanity or are defamatory will be deleted. There may be other circumstances that will require us to remove a comment. Organon reserves the right to delete any posting at its sole discretion. We encourage you to respect fellow community members and follow Facebook's Statements of Rights and Responsibilities. This page is intended to provide a forum for open discussion and the content provided by those other than Organon does not represent the opinions or positions of Organon. The content available on this page is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Organon recommends that you consult your healthcare provider regarding personal health matters. Privacy:

Organon may collect information about you, such as your name and/or user name and the comments you post to understand and address perspectives about our company mission, strategy, practices, developments within our business and in healthcare and for legal and regulatory purposes. For more information about Organon's privacy practices, please read our Privacy Commitment at www.organon.com/privacy.

12/19/2025

Recently we came together for our year-end Founders’ Forum (our unique spin on a town hall). This meeting gave us all the opportunity to reflect on the past year and the impact Organon Founders have had around the world. In these stories, we see great resilience and dedication to our mission of improving the health of people throughout their lives and advancing women’s health.

Thank you to all Founders for being part of this journey and for helping us create a healthier future for generations to come. Wishing you and your loved ones a joyful, peaceful holiday season and a bright year ahead.

12/18/2025

Our purpose drives our momentum, and Organon teams around the world took meaningful actions and celebrated our progress. We’re energized to carry this momentum into 2026 – staying focused on what matters most: our commitment to delivering impactful medicines and solutions for a healthier every day. 🌍✨

Organon Latam won the ‘best innovation in advertising’ award in the SaludFestival for it’s We Accelerate Action to Celebrate your Future campaign, launched on International Women’s Day. What if we could meet our future selves? This is what four women experienced, with the help of artificial intelligence, who discovered that by taking action for their goals, they can achieve them.

Organon Egypt participated in the Population, Health & Development Conference , where we moderated a panel on building universal and inclusive social protection systems to advance economic justice, women’s health, and human development. We also contributed to another panel, sharing our expertise on how social determinants impact disease burden and health outcomes.

Organon South Africa convened with key partners for the Uganda Workshop on Sustainable Financing for Women’s Health, exploring innovative, home-grown approaches to financing women’s health and advancing sexual and reproductive health (SRH) outcomes that can strengthen Uganda’s SRH ecosystem and support the government’s long-term vision for women’s health.

Organon Korea and the Women's Leaders Network co-hosted the '8th Future Women's Economic Forum' and discussed ways to expand the social and economic roles of middle-aged women and improve their health.

Organon Northwest Europe the Cramlington manufacturing site in Northeast England proudly celebrated its 50 anniversary. This leading hub for solid dose tablet manufacturing supplies over 3 billion tablets to 140 countries each year.

At our newly acquired product site in Oss, Netherlands, we unveiled our latest mural symbolizing our commitment to supporting families on their fertility journeys, continuing a tradition across Organon’s production locations.

12/16/2025

At Organon, our end-of-year Founders Forum is more than a town hall—it’s a moment to reflect, celebrate, and look ahead. This year, we spotlighted our biosimilars portfolio, a cornerstone of growth for Organon.

Joe Azzinaro, Global Commercial Lead, Biosimilars, led a dynamic panel discussion with Satbir Kaur, Head of Alliance Management and Integration, and Mike Casia, Interim Head of U.S. Commercial & Government Affairs. Together, they shared insights into how we’re shaping the future of biosimilars:

- Through collaboration and integration with our collaborators, Organon helps expand access to potentially more affordable biosimilar treatments, with the goal of creating more sustainable healthcare systems

- Organon’s strong global commercial capability mixed with localized ex*****on strategy, complements the capabilities of our collaborators’ in the development and manufacturing for biosimilars

- Patients are at the heart of Organon’s mission, and our support programs, where available, help them gain access to Organon’s biosimilar options

We’re proud of the progress we’ve made and energized for what’s ahead. The momentum is clear: we’re .

12/15/2025

Migraine disproportionately affects women and remains widely underdiagnosed and undertreated. At in Lisbon, we spotlighted the need for a differentiated approach to care, including the importance of collaboration between neurologists and gynecologists in addressing the unique hormonal triggers women face.

See the highlights in our official recap, featuring insights from medical experts, Organon’s perspectives, and attendees’ reactions to our virtual reality migraine with aura simulation.

Our commitment is clear: we are working to advance innovative migraine care with both acute and preventive treatment options, supporting women across every stage of life.

European Headache Federation EHF

12/10/2025

can often cause debilitating symptoms that may interrupt an individual’s daily living, including family life, work, education, and relationships. Yet too often it’s dismissed as just a headache.

Miss Understood is shining a light on what living with migraine really means. At Organon, we’re committed to helping people advocate for themselves, have meaningful conversations with their healthcare providers, and provide acute and preventive treatment options.

12/04/2025

For some people, the start of a can include visual changes including seeing spots, flashes, zigzags. These symptoms, often known as , highlight the complex sensory nature of this condition.

The medical community continues to explore ways to support people living with neurological conditions like migraine. As a company focused on women’s health, we prioritize acute and preventative treatments for people who experience migraines.

We look forward to attending this year’s European Headache Federation EHF Congress, where we remain committed to supporting better access to innovative and comprehensive care in migraine.

12/02/2025

When a hits, it may feel like a sudden, overwhelming storm. Migraine is much more than “just a headache,” it is a neurological condition that may have debilitating symptoms that disrupts daily life in unexpected ways, especially for women who are disproportionately impacted by migraine.

As global conversations around migraine care continue to grow, we recognize the overwhelming impact migraine has on women. That's why we've made treating migraine a priority, driven by our focus: Here for her health.

Attending this year’s European Headache Federation EHF Congress, we are reminded of the importance of supportive, treatment options that are tailored to an individual patient's needs and the need for innovative and comprehensive care options, including both acute and preventative care. We’re committed to delivering impactful solutions for a healthier every day and enhancing the understanding of the unmet needs of those living with migraine.

12/01/2025

At the International Conference on Family Planning, we reflected on the progress in family planning and the critical work still ahead. Every woman deserves access to modern contraception, regardless of income, geography, or marital status. Through strong partnerships and Organon’s commitment to reach 100 million women and help reduce unplanned pregnancy, we are turning commitments into real access and equity outcomes–from global strategy to programs like the sustainable financing initiatives.

European Parliamentary Forum for Sexual & Reproductive Rights, Family Planning 2030

11/27/2025

As our U.S.-based Founders celebrate this year, we’re grateful for the healthcare professionals who show up every day for patients—and for our resilient Founders working to improve the health of people throughout their lives, advance women’s health, and build a healthier world.

11/20/2025

is more than a skin condition, it’s a chronic, immune-mediated inflammatory disease that may affect the whole body and mind. Beyond the visible signs and symptoms, it may also be associated with higher rates of cardiovascular disease, psoriatic arthritis and mental health conditions like depression.

Recognizing these connections may help support earlier, integrated care, which is why we’re working to help those living with psoriasis get access to treatment options earlier in their journey.

11/12/2025

Our Misses of Health characters are saying thanks, birth control - for offering more than pregnancy prevention such as access and choice when it comes to finding the right birth control option. That’s why they’re taking a moment to say thanks for helping women with their reproductive goals and family planning journey.

From short-acting contraceptives to long-acting reversible contraceptives, also referred to as LARCs, there are numerous birth control options available for women to decide what is best for them.

At Organon, we continue to support women in having access to birth control options.

Intended for U.S. audiences only.

Address

30 Hudson Street
Jersey City, NJ
07302

Website

http://www.organon.com/

Alerts

Be the first to know and let us send you an email when Organon posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Organon:

Shortcuts

Want your practice to be the top-listed Clinic in Jersey City?